BridgeBio have significantly advanced its progress of the new treatment for ATTR-CM, leveraging Attruby. Early trial data suggests promising outcomes for individuals suffering with this serious condition. This focus https://biotech150581.alltdesign.com/bridgebio-progresses-amyloidosis-treatment-with-the-drug-60875678